CSX Corporation Announces Date for Fourth Quarter Earnings Release and Earnings Call
18. Dezember 2024 10:00 ET
|
CSX Corporation
JACKSONVILLE, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release fourth quarter financial and operating results after the market close on Thursday, January 23, 2025. This...
CSX Corp Announces Date for Fourth Quarter Earnings Release and Earnings Call
04. Januar 2024 10:00 ET
|
CSX Corporation
JACKSONVILLE, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release fourth quarter financial and operating results after the market close on Wednesday, January 24, 2024. This...
CSX Corporation Announces Date for Third Quarter Earnings Release and Earnings Call
21. September 2023 11:00 ET
|
CSX Corporation
JACKSONVILLE, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) will release third quarter financial and operating results after the market close on Thursday, October 19, 2023. This...
Dynacor Reports a Quarterly Record Net Income of $5.1 Million in Q1-2022 (US$0.13 or CA$0.16 Per Share) and Sales of $50.1 Million
16. Mai 2022 07:30 ET
|
Dynacor
MONTREAL, May 16, 2022 (GLOBE NEWSWIRE) -- Dynacor Gold Mines Inc. (TSX: DNG) (Dynacor or the Corporation) released its unaudited condensed interim consolidated financial statements and the...
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
06. Mai 2021 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
Paltusotine Phase 3 PATHFNDR program in acromegaly initiated in 2Q 2021 Phase 1 data for CRN04894 and CRN04777 expected in mid-2021 SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Crinetics...
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
30. März 2021 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
Advancing paltusotine into a Phase 3 program for acromegaly following an FDA meeting Phase 1 clinical proof-of-concept data for CRN04894 and CRN04777 expected in 1H 2021 and mid-2021, respectively ...
Medicine Man Technologies Reports Third Quarter 2017 Results
13. November 2017 08:45 ET
|
Medicine Man Technologies, Inc.
Denver, CO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- DENVER, CO, November 13 2017 -- Medicine Man Technologies Inc. (OTCQB: MDCL), one of the United States' leading cannabis branding and consulting...
New Resource Bank reports fourth quarter 2016 financial results
30. Januar 2017 15:12 ET
|
New Resource Bank
SAN FRANCISCO, Jan. 30, 2017 (GLOBE NEWSWIRE) -- New Resource Bank (OTC Link LLC:NWBN) has announced unaudited financial results for the fourth quarter ended December 31, 2016. The bank finished...
SouthCrest Financial Group Reports Closure of $17.5 Million Capital Raise and Charter Consolidation Application With Preliminary 3Q13 Financial Results
24. Oktober 2013 16:30 ET
|
SouthCrest Financial Group, Inc.
PEACHTREE CITY, Ga., Oct. 24, 2013 (GLOBE NEWSWIRE) -- Kenneth H. Maloy, President and CEO of SouthCrest Financial Group, Inc. (SCSG:PK) announced today that the company reported preliminary results...
SouthCrest Financial Group Reports Preliminary 2Q13 Financial Results and $17.5 Million Capital Raise
01. August 2013 16:00 ET
|
SouthCrest Financial Group, Inc.
PEACHTREE CITY, Ga., Aug. 1, 2013 (GLOBE NEWSWIRE) -- Kenneth H. Maloy, President and CEO of SouthCrest Financial Group, Inc. (OTCBB:SCSG), announced today that the company reported preliminary...